Nephrostomy Devices Market
Nephrostomy Devices Market Forecasts to 2030 - Global Analysis By Product Type (Nephrostomy, Catheters, Guidewires, Dilators Sheaths, Drainage Tubes and Other Product Types), End User (Ambulatory Surgical Centers, Emergency Clinics, Hospitals and Other End Users), and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $1,500.5 MN |
|
Projected Year Value (2030) |
US $2,887.1 MN |
|
CAGR (2023 - 2030) |
9.8% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Nephrostomy Devices Market is accounted for $1,500.5 million in 2023 and is expected to reach $2,887.1 million by 2030 growing at a CAGR of 9.8% during the forecast period. To drain urine from the kidney, a thin, flexible tube called a nephrostomy tube is inserted through the skin. The tube is utilized to temporarily discharge obstructed pee. A plastic bag is connected to the tube outside the body to collect the fluid. Nephrostomies can help keep the kidneys healthy and shield them from injury and infection. A nephrostomy device can also aid in the diagnosis of an underlying issue since the ureter can be seen using ultrasonography, X-rays, and contrast material injection.
According to the Kidney Foundation Canada, kidney stones are common in Canada and appear to be on the rise, especially over the last 25 years. About 12% of men and 6% of women will have a kidney stone at some point in their life.
Market Dynamics:
Driver:
Rising incidence of urological disorders
Increased incidence of urological conditions such as hydronephrosis, kidney stones, urine retention, bladder cancer, and prostate cancer and the rise in percutaneous nephrostomy treatments are the main factors impacting the market throughout the projected period. Furthermore, the geriatric population is more susceptible to chronic illnesses that need long-term care, such as incontinence, digestive difficulties, and chronic ailments. Therefore, a high-impact driver is anticipated to be an increase in the world's senior population. Additionally, the number of urological procedures performed will climb along with the aging population, which drives market growth.
Restraint:
Entailing negative outcomes
One frequent concern is infection at the location where the nephrostomy tube is placed. Healthcare professionals take preventative measures to reduce this risk, including employing sterile procedures during the treatment and giving patients the right care and maintenance instructions. During or after the nephrostomy surgery, bleeding is possible, which can happen in exceptional circumstances and call for additional medical attention. Some individuals may experience an allergic response to the components of the dressing or nephrostomy tube. There may be slight bleeding, discomfort, or pain at the removal site when the nephrostomy tube is no longer required, thus hampering the growth of the market.
Opportunity:
Rise in demand for minimal invasive operations
Over the course of the forecast period, factors like a rise in demand for less invasive operations and technical developments in nephrostomy devices with a high success rate will drive the market. For patients experiencing pain due to kidney obstruction or infections, a nephrostomy can provide significant pain relief by alleviating the pressure and reducing inflammation in the kidney. It also allows the kidney to continue filtering waste and maintaining fluid balance, creating a wide range of opportunities for market growth.
Threat:
Availability of alternative procedures
The availability of alternatives to nephrostomy surgery can affect patient care in both positive and negative ways, as different procedures may be chosen without a careful assessment of the patient's needs and medical condition, which carries both potential risks for their care. This may result in the decision to take an unsuitable course of action, which may provide less than ideal results or cause difficulties. Various factors, including the experience of the healthcare professional and the accessibility of resources, can have a significant impact on the quality of alternative operations.
Covid-19 Impact
The initial wave of COVID-19 had a substantial influence on the market for nephrostomy devices because of the delays in nephrology-related procedures and consultations brought on by the global lockdown. The COVID-19 outbreak forced urology departments worldwide to restructure care owing to insufficient resources and manpower. However, as the regulations are loosened, the market is anticipated to expand in the years to come as a result of the rise in renal disorders and the increased use of nephrostomy devices.
The guidewires segment is expected to be the largest during the forecast period
The guidewires segment is estimated to have significant growth because of its ability to gain access and aid transit across different luminal structures. A guidewire is an effective instrument. To make the placement of endourological tools during diagnostic or interventional procedures easier, urological guidewires are used. Due to the rise in renal issues and the desire for minimally invasive kidney disease manufacturers, the rising incidence of kidney stone disorders, the frequency of ovarian, bladder, and prostate malignancies, and the rising desire for less invasive surgical treatments are anticipated to raise the need for guidewires during nephrostomy procedures, which is predicted to encourage market expansion.
The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period
The ambulatory surgical centers segment is anticipated to witness the highest CAGR during the forecast period, as they provide more individualized services and greater results in comparison to hospitals and other healthcare settings. Additionally, ASCs do not have to deal with the issue of treating a variety of diseases and disorders; they can guarantee that patients receive tailored attention with a better patient experience, thus enhancing the growth of the market.
Region with largest share:
North America is projected to hold the largest market share during the forecast period due to the advantageous reimbursement rules, rising product awareness, the availability of highly qualified physicians, and the existence of established healthcare facilities in the area. In addition to the rapid use of technologically improved medical goods, the rise in the prevalence of kidney stones in the region is expected to increase the demand for nephrostomy devices.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the establishment of medical facilities such as hospitals, clinics, and urology specialty centers. This raises the need for nephrostomy devices by making healthcare services more accessible to those who need nephrostomy surgeries. Additionally, regional governments are enacting laws and launching efforts to upgrade the healthcare system and promote the use of cutting-edge medical technologies. This covers reimbursement plans and financial aid for urological procedures, thus propelling the growth of the market.
Key players in the market
Some of the key players profiled in the Nephrostomy Devices Market include Angiodynamics Inc, Argon Medical, B. Braun Melsungen AG., Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Coloplast Group, Cook Group (Cook Medical Incorporated), Envaste Limited, Medi-Globe GmbH, Meditech Devices Pvt Ltd, Olympus Corporation, Straub Medical AG, SURU International Pvt. Ltd, Teleflex Incorporated and Uresil LLC
Key Developments:
In August 2023, Cardinal health launches next generation medical device to improve neonatal feeding, through real-time assessment technology, the NTrainer™ System provides clinicians with the objective data they need to track the progress of an infant in developing pre-feeding skills.
In June 2023, Becton, Dickinson and Company a leading global medical technology company, announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS for $540 million.
In May 2023, Argon Strengthens Biopsy Portfolio with SuperCore Advantage™ Instrument. The SuperCore Advantage is a disposable, next generation soft tissue biopsy instrument that provides a superior volume of tissue sample.
Product Types Covered:
• Nephrostomy Catheters
• Guidewires
• Dilators Sheaths
• Drainage Tubes
• Other Product Types
End Users Covered:
• Ambulatory Surgical Centers
• Emergency Clinics
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Nephrostomy Devices Market, By Product Type
5.1 Introduction
5.2 Nephrostomy Catheters
5.3 Guidewires
5.4 Dilators Sheaths
5.5 Drainage Tubes
5.6 Other Product Types
6 Global Nephrostomy Devices Market, By End User
6.1 Introduction
6.2 Ambulatory Surgical Centers
6.3 Emergency Clinics
6.4 Hospitals
6.5 Other End Users
7 Global Nephrostomy Devices Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Angiodynamics Inc
9.2 Argon Medical
9.3 B. Braun Melsungen AG
9.4 Becton, Dickinson and Company
9.5 Boston Scientific Corporation
9.6 Cardinal Health
9.7 Coloplast Group
9.8 Cook Group (Cook Medical Incorporated)
9.9 Envaste Limited
9.10 Medi-Globe GmbH
9.11 Meditech Devices Pvt Ltd
9.12 Olympus Corporation
9.13 Straub Medical AG
9.14 SURU International Pvt. Ltd
9.15 Teleflex Incorporated
9.16 Uresil LLC
List of Tables
1 Global Nephrostomy Devices Market Outlook, By Region (2021-2030) ($MN)
2 Global Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
4 Global Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
5 Global Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
6 Global Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
7 Global Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
8 Global Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
9 Global Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
10 Global Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
11 Global Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
12 Global Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
13 North America Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
14 North America Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
15 North America Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
16 North America Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
17 North America Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
18 North America Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
19 North America Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
20 North America Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
21 North America Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
22 North America Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
23 North America Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
24 North America Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
25 Europe Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
26 Europe Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
27 Europe Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
28 Europe Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
29 Europe Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
30 Europe Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
31 Europe Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
32 Europe Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
33 Europe Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
34 Europe Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
35 Europe Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
36 Europe Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
37 Asia Pacific Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
38 Asia Pacific Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
39 Asia Pacific Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
40 Asia Pacific Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
41 Asia Pacific Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
42 Asia Pacific Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
43 Asia Pacific Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
44 Asia Pacific Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
45 Asia Pacific Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
46 Asia Pacific Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
47 Asia Pacific Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
48 Asia Pacific Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
49 South America Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
50 South America Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
51 South America Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
52 South America Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
53 South America Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
54 South America Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
55 South America Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
56 South America Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
57 South America Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
58 South America Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
59 South America Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
60 South America Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
61 Middle East & Africa Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
62 Middle East & Africa Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
63 Middle East & Africa Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
64 Middle East & Africa Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
65 Middle East & Africa Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
66 Middle East & Africa Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
67 Middle East & Africa Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
68 Middle East & Africa Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
69 Middle East & Africa Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
70 Middle East & Africa Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
71 Middle East & Africa Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
72 Middle East & Africa Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
